Medfinder
Back to blog

Updated: January 20, 2026

How to Help Your Patients Find Travoprost in Stock: A Provider's Guide

Author

Peter Daggett

Peter Daggett

Travoprost blog post header image

A practical guide for ophthalmologists and optometrists on helping patients find travoprost when their pharmacy is out of stock in 2026.

For eye care providers managing patients on travoprost (Travatan Z), medication access issues are a real — if underappreciated — barrier to successful IOP control. Patients who cannot fill their prescription may not call your office; they may simply go without. This guide gives you a practical, clinic-ready workflow for addressing travoprost access problems and preventing treatment gaps that could lead to optic nerve damage and vision loss.

Why Travoprost Access Problems Happen (Even Without a Shortage)

Travoprost is not in national shortage, but individual pharmacy stockouts are common for several structural reasons. Retail pharmacy chains typically stock a single generic manufacturer's product. If that manufacturer has any production or distribution delay, the entire chain in a geographic area may run out. Independent pharmacies are often more flexible about ordering alternatives, but patients don't always know to try them.

Additionally, preservative-related formulation preferences (sofZia vs. BAK) mean some patients specifically need brand Travatan Z or an ionic-buffered generic, which may be stocked less commonly than standard BAK-preserved generics. And insurance formulary restrictions — including step therapy requirements and quantity limits — add another layer of friction.

Step 1: Ask Directly at Every Glaucoma Visit

The single highest-yield intervention is simply asking: 'Have you been able to fill your travoprost prescription without any problems?' Many patients — particularly elderly patients on fixed incomes — will not volunteer that they've been skipping doses due to cost or availability issues. Normalizing the question removes the stigma and surfaces problems early, before IOP has rebounded.

If the patient reports problems, document this in the chart as a clinical concern. Cost-related or access-related non-adherence is clinically significant and should be treated with the same urgency as other barriers to care.

Step 2: Check Formulary Before Prescribing

Before writing a new travoprost prescription, run a quick formulary check using your EHR's built-in tools or a smartphone app. Travoprost falls on different tiers across plans — sometimes Tier 1 (preferred generic), sometimes Tier 3 or higher (non-preferred). If travoprost will require step therapy or high cost-sharing on a specific plan, proactively prescribe latanoprost instead (if clinically equivalent for that patient) to avoid prior auth delays.

Step 3: Train Staff to Provide Savings Card Information at Checkout

GoodRx and SingleCare discount cards can reduce the cash price of generic travoprost to $28–50 per bottle — from a retail price of $190+. Designate a staff member to hand out savings card information with every new glaucoma prescription. Print out or display the QR codes for GoodRx and SingleCare at your checkout desk. A 30-second conversation can save a patient $100–150 per month.

Step 4: Have a Standing Substitution Protocol

Establish a protocol that your staff can initiate when a patient calls reporting that their pharmacy is out of travoprost. The protocol should include:

Step 1: Direct patient to call at least two other pharmacies, or use medfinder.

Step 2: If unavailable within 24–48 hours, provider sends an e-prescription for latanoprost (1 bottle, 30-day supply).

Step 3: Patient resumes travoprost as soon as it becomes available; latanoprost is discontinued.

Step 4: Document the temporary switch and reason in the chart.

Step 5: Use medfinder to Help Patients Find Travoprost

Rather than having your staff or the patient call five or ten pharmacies, recommend medfinder for Providers. medfinder calls pharmacies on the patient's behalf and texts them the results — including which locations have the medication in stock and in what quantity. This is particularly helpful for patients with limited mobility, vision impairment, or other barriers to self-advocacy.

Step 6: Consider 90-Day Mail-Order Prescriptions for Stable Patients

For patients with well-controlled IOP who are stable on travoprost, switching to mail-order 90-day supply prescriptions eliminates the risk of local pharmacy stockouts. Mail-order pharmacies carry large inventory and are rarely affected by the local stock variability that impacts retail chains. Many Medicare Part D and commercial plans incentivize mail-order with lower copays. Offer to write 90-day prescriptions for eligible patients.

Key Prescribing Tips for Travoprost in 2026

For most patients: allow generic substitution — it's equally effective and dramatically cheaper

For OSD patients: specify ionic-buffered formulation (Travatan Z or equivalent) to avoid BAK exposure

Never combine two prostaglandin analogs — combination reduces efficacy or raises IOP paradoxically

Dose travoprost once daily in the evening only — more frequent dosing may decrease effectiveness

Not recommended in children under 16 due to pigmentation safety concerns

For a supply briefing, see: Travoprost Shortage: What Providers and Prescribers Need to Know in 2026.

For savings and affordability strategies, see: How to Help Your Patients Save Money on Travoprost: A Provider's Guide to Savings Programs.

Frequently Asked Questions

First, advise them to call one or two other pharmacies or use medfinder to locate stock quickly. If they can't find it within 24–48 hours, consider calling in a 30-day supply of latanoprost as a bridge. Remind them not to use both drugs simultaneously — one prostaglandin at a time. Document the access issue in the chart.

For most patients, generic substitution is appropriate. Generic travoprost is bioequivalent and can cost $28–50 with a discount card vs. $190+ cash retail for brand. For patients with ocular surface disease or documented preservative sensitivity, specifying the ionic-buffered formulation (Travatan Z or equivalent) is clinically justified — be prepared for a prior authorization.

Establish a standing protocol. Train one staff member as the 'cost and access navigator.' Provide GoodRx/SingleCare handouts at checkout for every glaucoma prescription. Recommend medfinder for patients who cannot find their medication — the service calls pharmacies on their behalf so neither staff nor the patient has to spend time calling around.

Yes, for most patients this is a straightforward within-class substitution. Both are prostaglandin F2α analogs with similar IOP-lowering efficacy. Advise the patient to stop travoprost completely before starting latanoprost. Schedule a follow-up IOP check within 4–6 weeks of any medication change to confirm adequate control on the alternative.

Travoprost maintains IOP-lowering activity for up to 84 hours post-dose, so a brief gap of 1–2 days poses minimal acute risk for most patients. Extended gaps of a week or more allow IOP to return toward baseline, which is concerning for patients with advanced disease or very high target pressures. Advise patients to contact your office if they anticipate missing more than 2–3 days.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Travoprost also looked for:

30,239 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,239 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?